Healthcare Sector

Members of Parliament invested in the Healthcare Sector

156 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£135.41	213.16%	£219,211.37
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£134.54	191.65%	£204,157.80
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£13,338.00	10.93%	£77,649.70
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£13,338.00	224.05%	£226,836.73
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£13,338.00	244.07%	£240,851.28
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£13,338.00	79.71%	£125,796.28
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£13,338.00	13.28%	£79,298.45
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£13,520.00	407.03%	£354,922.18
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£13,520.00	11.22%	£77,854.56
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£13,520.00	149.58%	£174,709.25
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£13,520.00	13.38%	£79,369.34
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£13,520.00	32.16%	£92,512.22
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£13,520.00	68.89%	£118,226.11
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£13,520.00	360.18%	£322,123.89
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£1.54	-53.47%	£32,567.98
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£48.07	28.56%	£89,994.65
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£48.07	-10.03%	£62,977.73
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£47.65	11.38%	£77,968.68
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£47.65	21.00%	£84,700.36
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£47.65	12.62%	£78,834.79
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£47.65	20.66%	£84,464.42
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£47.65	6.48%	£74,536.32
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£48.07	9.20%	£76,440.25
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£47.65	27.51%	£89,256.09
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£218.01	32.10%	£92,472.28
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£218.21	77.93%	£124,549.09
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£218.21	200.19%	£210,134.82
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£218.21	258.13%	£250,692.61
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£218.21	34.93%	£94,451.52
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£234.33	224.76%	£227,333.78
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£234.33	-5.85%	£65,906.88
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£347.75	37.33%	£96,131.82
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£338.43	-30.94%	£48,341.22
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£338.43	-37.07%	£44,047.56
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£338.43	-34.69%	£45,716.13
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£338.43	-43.06%	£39,855.48
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£338.43	-6.29%	£65,596.29
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,442.93	114.57%	£150,195.70
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£636.30	52.17%	£106,521.73
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£619.01	34.79%	£94,353.07
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£619.01	6.06%	£74,242.17
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£619.01	33.68%	£93,578.74
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£619.01	29.66%	£90,762.03
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£160.90	-73.73%	£18,385.57
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£150.50	-52.97%	£32,921.88
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£59.32	63.19%	£114,233.84
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£60.68	-40.33%	£41,770.08
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£60.68	-50.57%	£34,603.67
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£60.68	-54.94%	£31,543.14
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£125.08	-25.59%	£52,085.66
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£123.24	-24.31%	£52,983.66
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£145.11	64.19%	£114,932.12
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£145.11	119.70%	£153,791.80
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£143.58	165.69%	£185,980.27
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£178.20	-21.67%	£54,830.77
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£346.00	37.38%	£96,168.35
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£346.00	11.74%	£78,217.34
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£346.00	35.26%	£94,683.35
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£346.00	14.19%	£79,933.99
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£346.00	11.97%	£78,381.88
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£121.14	379.45%	£335,617.43
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£121.14	11.32%	£77,925.01
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£121.14	268.21%	£257,744.66
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£16.83	-83.37%	£11,641.30
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£25.52	30.57%	£91,401.24
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£25.52	-12.07%	£61,551.67
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£32.17	42.31%	£99,619.36
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£32.17	53.33%	£107,333.55
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£383.86	340.76%	£308,533.70
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£359.61	418.02%	£362,614.52
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£359.61	30.77%	£91,537.09
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£47.05	-1.57%	£68,901.67
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£47.05	-14.38%	£59,936.30
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£8.92	-30.37%	£48,743.17
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£98.60	-2.15%	£68,492.61
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£80.09	0.82%	£70,572.75
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£42.92	-54.95%	£31,535.27
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£165.55	-39.53%	£42,332.42
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£214.04	33.10%	£93,170.82
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£527.44	89.83%	£132,880.33
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£527.44	50.36%	£105,250.43
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£523.69	-5.01%	£66,494.29
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.85	10.63%	£77,442.53
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£464.38	1,397.03%	£1,047,923.93
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£28.40	13.55%	£79,487.56
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,765.00	3.25%	£72,274.09
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£686.02	2,189.79%	£1,602,850.57
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£1,041.29	42.38%	£99,668.14
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,527.00	-24.63%	£52,759.13
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£2.27	-94.76%	£3,670.59
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£888.20	59.46%	£111,622.98
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£5.92	322.86%	£296,000.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.39	-52.45%	£33,281.91
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£3.48	81.25%	£126,875.00
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£1.03	-0.96%	£69,326.92
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£30.94	105.58%	£143,906.98
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.55	-95.42%	£3,208.33
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£7.41	-30.23%	£48,841.81
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£6.00	-46.67%	£37,333.33
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£39.09	29.95%	£90,967.42
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£43.00	-61.60%	£26,879.80
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£372.90	10.95%	£77,664.38
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£6.90	-45.45%	£38,181.82
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£267.20	28.77%	£90,139.76
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£267.20	-2.20%	£68,462.66
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.73	-97.21%	£1,951.92
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£53.00	-52.68%	£33,125.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£53.00	2.91%	£72,038.83
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£72.17	313.11%	£289,175.74
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£3.52	-88.27%	£8,213.33
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£4.01	1.52%	£71,063.29

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.